65 related articles for article (PubMed ID: 11228748)
1. Effect of hyperketonemia on blood monocytes in type-I diabetic patients and apoptosis in cultured U937 monocytes.
Jain SK; Kannan K; McVie R
Antioxid Redox Signal; 1999; 1(2):211-20. PubMed ID: 11228748
[TBL] [Abstract][Full Text] [Related]
2. Hyperketonemia increases tumor necrosis factor-alpha secretion in cultured U937 monocytes and Type 1 diabetic patients and is apparently mediated by oxidative stress and cAMP deficiency.
Jain SK; Kannan K; Lim G; McVie R; Bocchini JA
Diabetes; 2002 Jul; 51(7):2287-93. PubMed ID: 12086962
[TBL] [Abstract][Full Text] [Related]
3. Elevated blood interleukin-6 levels in hyperketonemic type 1 diabetic patients and secretion by acetoacetate-treated cultured U937 monocytes.
Jain SK; Kannan K; Lim G; Matthews-Greer J; McVie R; Bocchini JA
Diabetes Care; 2003 Jul; 26(7):2139-43. PubMed ID: 12832326
[TBL] [Abstract][Full Text] [Related]
4. Hyperketonemia can increase lipid peroxidation and lower glutathione levels in human erythrocytes in vitro and in type 1 diabetic patients.
Jain SK; McVie R
Diabetes; 1999 Sep; 48(9):1850-5. PubMed ID: 10480618
[TBL] [Abstract][Full Text] [Related]
5. Hyperketonemia (acetoacetate) increases the oxidizability of LDL + VLDL in Type-I diabetic patients.
Jain SK; McVie R; Jaramillo JJ; Chen Y
Free Radic Biol Med; 1998 Jan; 24(1):175-81. PubMed ID: 9436628
[TBL] [Abstract][Full Text] [Related]
6. Hyperketonemia increases monocyte adhesion to endothelial cells and is mediated by LFA-1 expression in monocytes and ICAM-1 expression in endothelial cells.
Rains JL; Jain SK
Am J Physiol Endocrinol Metab; 2011 Aug; 301(2):E298-306. PubMed ID: 21540444
[TBL] [Abstract][Full Text] [Related]
7. Hyperketonemia and ketosis increase the risk of complications in type 1 diabetes.
Kanikarla-Marie P; Jain SK
Free Radic Biol Med; 2016 Jun; 95():268-77. PubMed ID: 27036365
[TBL] [Abstract][Full Text] [Related]
8. Elevated acetoacetate and monocyte chemotactic protein-1 levels in cord blood of infants of diabetic mothers.
Kurepa D; Pramanik AK; Kakkilaya V; Caldito G; Groome LJ; Bocchini JA; Jain SK
Neonatology; 2012; 102(3):163-8. PubMed ID: 22776897
[TBL] [Abstract][Full Text] [Related]
9. Hyperketonemia decreases mitochondrial membrane potential and its normalization with chromium (III) supplementation in monocytes.
Rains JL; Jain SK
Mol Cell Biochem; 2011 Mar; 349(1-2):77-82. PubMed ID: 21153866
[TBL] [Abstract][Full Text] [Related]
10. Effect of acute hyperketonemia on the cerebral uptake of ketone bodies in nondiabetic subjects and IDDM patients.
Blomqvist G; Alvarsson M; Grill V; Von Heijne G; Ingvar M; Thorell JO; Stone-Elander S; Widén L; Ekberg K
Am J Physiol Endocrinol Metab; 2002 Jul; 283(1):E20-8. PubMed ID: 12067838
[TBL] [Abstract][Full Text] [Related]
11. Effect of hyperketonemia on plasma lipid peroxidation levels in diabetic patients.
Jain SK; McVie R; Jackson R; Levine SN; Lim G
Diabetes Care; 1999 Jul; 22(7):1171-5. PubMed ID: 10388984
[TBL] [Abstract][Full Text] [Related]
12. High glucose and ketosis (acetoacetate) increases, and chromium niacinate decreases, IL-6, IL-8, and MCP-1 secretion and oxidative stress in U937 monocytes.
Jain SK; Rains JL; Croad JL
Antioxid Redox Signal; 2007 Oct; 9(10):1581-90. PubMed ID: 17665966
[TBL] [Abstract][Full Text] [Related]
13. 1,25(OH)2D3 inhibits oxidative stress and monocyte adhesion by mediating the upregulation of GCLC and GSH in endothelial cells treated with acetoacetate (ketosis).
Kanikarla-Marie P; Jain SK
J Steroid Biochem Mol Biol; 2016 May; 159():94-101. PubMed ID: 26949104
[TBL] [Abstract][Full Text] [Related]
14. Alcoholic ketoacidosis at autopsy.
Pounder DJ; Stevenson RJ; Taylor KK
J Forensic Sci; 1998 Jul; 43(4):812-6. PubMed ID: 9670504
[TBL] [Abstract][Full Text] [Related]
15. Hyperketonemia induces upregulation of LFA-1 in monocytes, which is mediated by ROS and P38 MAPK activation.
Rains JL; Kanikarla-Marie P; Jain SK
Can J Physiol Pharmacol; 2012 Dec; 90(12):1642-6. PubMed ID: 23210443
[TBL] [Abstract][Full Text] [Related]
16. Hyperketonemia (ketosis), oxidative stress and type 1 diabetes.
Jain SK; McVie R; Bocchini JA
Pathophysiology; 2006 Aug; 13(3):163-70. PubMed ID: 16782314
[TBL] [Abstract][Full Text] [Related]
17. [The characteristics of the peripheral blood monocytes in diabetics].
Galenok VA; Zhuk EA
Ter Arkh; 1997; 69(2):59-62. PubMed ID: 9173581
[TBL] [Abstract][Full Text] [Related]
18. Determination of ketone bodies in blood by headspace gas chromatography-mass spectrometry.
Holm KM; Linnet K; Rasmussen BS; Pedersen AJ
J Anal Toxicol; 2010 Nov; 34(9):549-54. PubMed ID: 21073807
[TBL] [Abstract][Full Text] [Related]
19. Conventional, but not high-purity, dialysate-induced monocyte apoptosis is mediated by activation of PKC-delta and inflammatory factors release.
Guo LL; Pan Y; Zhu XJ; Tan LY; Xu QJ; Jin HM
Nephrol Dial Transplant; 2011 May; 26(5):1516-22. PubMed ID: 20923925
[TBL] [Abstract][Full Text] [Related]
20. Human monocyte differentiation stage affects response to arachidonic acid.
Escobar-Alvarez E; Pelaez CA; García LF; Rojas M
Cell Immunol; 2010; 264(1):61-70. PubMed ID: 20537616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
